Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study

INTRODUCTION: Alopecia areata (AA) is an autoimmune hair loss mediated by CD8 + T cells. Treatment for moderate-to-severe AA is still challenging. Janus kinase inhibitors, such as tofacitinib, have been recently investigated as a promising treatment option for AA. Evidence on the combination use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenxin, Li, Xiangqian, Chen, Baifu, Zhang, Jianzhong, Torres-Culala, Kara Melissa T., Zhou, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255896/
https://www.ncbi.nlm.nih.gov/pubmed/35801202
http://dx.doi.org/10.3389/fmed.2022.891434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255896/
https://www.ncbi.nlm.nih.gov/pubmed/35801202
http://dx.doi.org/10.3389/fmed.2022.891434

Ejemplares similares